Department of Clinical Biochemistry, Rigshospitalet, Copenhagen, Denmark.
OPEN, Odense Patient Data Explorative Network, Odense University Hospital/Institute of Clinical Research, University of Southern Denmark, Odense, Denmark.
Osteoporos Int. 2019 May;30(5):1137-1141. doi: 10.1007/s00198-019-04837-7. Epub 2019 Jan 24.
Given that bone turnover markers are often shipped to central laboratories, it is essential to be aware of factors that will affect stability. We have evaluated how sample type, time before separation of blood samples, and time between separation and analysis affect the stability of four bone turnover markers.
Bone turnover markers are often shipped to central laboratories for analysis, which require knowledge of the stability of the markers of interest in different sample materials. The aim of the current study was to evaluate how time before separation of blood samples and time between separation and analysis affect the stability of four bone turnover markers in serum and plasma samples.
Serum, EDTA, and Lithium heparin (LiHep) plasma samples from seven osteoporosis patients and three healthy controls were collected and stored at room temperature for up to 72 h before separation and analysis. After separation, samples were stored at room temperature for up to 72 h and re-analyzed. The bone turnover markers N-terminal pro-collagen type 1 extension pro-peptide (P1NP), bone-specific alkaline phosphatase (BAP), C-terminal teleopeptide cross links of collagen type 1 (CTX), and osteocalcin (OC) were analyzed using the automated iSYS IDS platform.
P1NP and BAP were stable in both plasma and serum for 72 h before centrifugation. CTX levels were higher in EDTA plasma at all time points compared to LiHep plasma and serum. The use of EDTA plasma prolonged the stability of CTX as compared to LiHep plasma and serum. Osteocalcin showed high tendency to degrade in all sample types and concentrations were significantly lower after 24 h of storage.
For the bone turnover markers P1NP and BAP, the use of both plasma and serum is recommended. Samples for CTX analysis should be taken as EDTA plasma. Samples for osteocalcin analysis can be taken in either type of plasma or serum, but should be analyzed within 3 h or preserved at - 18 °C.
由于骨转换标志物通常被运送到中心实验室,因此了解会影响稳定性的因素至关重要。我们评估了样本类型、血液样本分离前的时间以及分离与分析之间的时间间隔如何影响四种骨转换标志物的稳定性。
骨转换标志物通常被运送到中心实验室进行分析,这就需要了解不同样本材料中感兴趣的标志物的稳定性。本研究的目的是评估在血清和血浆样本中,血液样本分离前的时间和分离与分析之间的时间间隔如何影响四种骨转换标志物的稳定性。
收集了 7 名骨质疏松症患者和 3 名健康对照者的血清、EDTA 和肝素锂(LiHep)血浆样本,并在分离和分析前在室温下储存长达 72 小时。分离后,将样本在室温下储存长达 72 小时,并进行重新分析。使用自动化 iSYS IDS 平台分析 N 端前胶原 C 端肽延伸 pro 肽(P1NP)、骨碱性磷酸酶(BAP)、I 型胶原 C 端肽交联(CTX)和骨钙素(OC)等骨转换标志物。
在离心前 72 小时内,P1NP 和 BAP 在血浆和血清中均稳定。在所有时间点,EDTA 血浆中的 CTX 水平均高于 LiHep 血浆和血清。与 LiHep 血浆和血清相比,使用 EDTA 血浆延长了 CTX 的稳定性。OC 在所有样本类型中都有较高的降解趋势,在储存 24 小时后浓度显著降低。
对于 P1NP 和 BAP 等骨转换标志物,建议同时使用血浆和血清。用于 CTX 分析的样本应采集为 EDTA 血浆。用于 OC 分析的样本可采集于任意类型的血浆或血清,但应在 3 小时内分析或保存在-18°C。